Clinical trial
Effects and Prognostic Factors of Intensive Pulse Light Treatment for Meibomian Gland Dysfunction
NCT03950115 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects and Prognostic Factors of Intensive Pulse Light Treatment for Meibomian Gland Dysfunction
- Lead sponsor
- Samsung Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 18, 2019
- Completion date
- April 10, 2020
- Enrollment
- 81 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.